Topical photodynamic therapy for primary cutaneous B-cell lymphoma: a pilot study

Moira Mori; Piero Campolmi; Luciano Mavilia; Riccardo Rossi; Pietro Cappugi; Nicola Pimpinelli

doi:10.1016/j.jaad.2005.10.016

Topical photodynamic therapy for primary cutaneous B-cell lymphoma: a pilot study

J Am Acad Dermatol. 2006 Mar;54(3):524-6. doi: 10.1016/j.jaad.2005.10.016.

Authors

Moira Mori¹, Piero Campolmi, Luciano Mavilia, Riccardo Rossi, Pietro Cappugi, Nicola Pimpinelli

Affiliation

¹ Physical Therapy Unit, University of Florence Medical School, Florence, Italy.

PMID: 16488310
DOI: 10.1016/j.jaad.2005.10.016

Abstract

Photodynamic therapy (PDT) is a treatment based on the accumulation of a photosensitizer in the target cells and their selective destruction by irradiation with visible light. In the past 10 years, several patients with cutaneous T cell lymphoma have been successfully treated. The use of PDT in cutaneous B cell lymphoma has not been reported to date. We report the successful PDT treatment of 3 patients with early primary cutaneous B cell lymphoma.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Female
Humans
Lymphoma, B-Cell / drug therapy*
Male
Middle Aged
Photochemotherapy*
Pilot Projects
Skin Neoplasms / drug therapy*